KATHRYN FEISAL: Open Payments
NPI 1255673349 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 15 payments from 11 companies in 2025. Trend: 2023 $1,167 · 2024 $709 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $62 |
| Antares Pharma, Inc. | 3 | $57 |
| COLOPLAST CORP | 1 | $32 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $25 |
| Teleflex LLC | 1 | $25 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $22 |
| Endo USA, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $18 |
| Boston Scientific Corporation | 1 | $18 |
Products named: PLUVICTO, XYOSTED, Titan, GEMTESA, Xtandi, BARRIGEL, PYLARIFY, XIAFLEX.
Industry payments across OK — which companies pay providers there.
